Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-11-16
1998-08-25
Trang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, 530331, 562445, 548496, A61K 3805
Patent
active
057983372
ABSTRACT:
The present invention comprises growth hormone releasing peptides/peptidomimetics (GHRP) capable of causing release of growth hormone from the pituitary. Compositions containing the GHRP's of this invention are used to promote growth in mammals either alone or in combination with other growth promoting compounds, especially IGF-1. In a method of this invention GHRP's in combination with IGF-1 are used to treat Type II diabetes. An exemplary compound of this invention is provided below. ##STR1##
REFERENCES:
patent: 4223020 (1980-09-01), Momany
patent: 4223021 (1980-09-01), Momany
patent: 4224313 (1980-09-01), Zimmerman et al.
patent: 4224316 (1980-09-01), Momany et al.
patent: 4226857 (1980-10-01), Momany
patent: 4228155 (1980-10-01), Momany
patent: 4228156 (1980-10-01), Momany
patent: 4228157 (1980-10-01), Momany et al.
patent: 4228158 (1980-10-01), Momany
patent: 4410512 (1983-10-01), Bowers
patent: 4410513 (1983-10-01), Momany
patent: 4411890 (1983-10-01), Momany
patent: 4839344 (1989-06-01), Bowers et al.
patent: 4880777 (1989-11-01), Momany
patent: 5206235 (1993-04-01), Fisher et al.
patent: 5246920 (1993-09-01), Bercu et al.
patent: 5268360 (1993-12-01), Yoshikawa
patent: 5283241 (1994-02-01), Bochis et al.
patent: 5663146 (1997-09-01), Bowers et al.
patent: 5663171 (1997-09-01), Chen et al.
Bowers et al., "On the in Vitro and in Vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone" Endocrinology 114(5) :1537-1545 (1984).
Bowers et al., "Structure-activity relationships of a synthetic pentapeptide that specifically release growth hormone in Vitro" Endocrinology 106(3) :663-667 (1980).
Bowers, C. Y., "GH Releasing Peptides--Structures and Kinetics" J. Pediatr. Endocrinology 6(1) :21-31 (1993).
Momany et al., "Conformational energy studies and in Vitro and in Vivo activity data on growth hormone-releasing peptides" Endocrinology 114(5) :1531-1536 (1984).
Momany et al., "Design, synthesis and biological activity of peptides which release growth hormone in Vitro" Endocrinology (108)1 :31-39 (1981).
Schoen et al., "Growth Hormone Secretagogues" Annual Reports in Medicinal Chemistry: Section IV-Endocrinology & Metabolic Diseases, William K. Hagmann, Chapter 19, vol. 28:177-186 (1993).
Schoen, W.R. et al., "Structure-activity relationships in the amino acid sidechain of L-692, 429" Bioorg & Medicinal Chem. Lett. 4(9) :1117-1122 (1994).
Smith, R.G. et al., "A nonpeptidyl growth hormone secretagogue" Science 260:1640-1643 (1993).
Wu, Danxing et al., "The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist" J. Endocrin. 140:R9-R13 (1994).
Deghenghi et al., "GH-Releasing Activity of Hexarelin, A New Growth Hormone Releasing Peptide, in Infant and Adult Rats" Life Sciences 54(18) :1321-1328 (1994).
Egorova et al., "Synthesis of shortened analogs of substance P with modification of the glutamine residue at position 6" Chemical Abstracts (abstract only) 116(11):abstract No. 106743 (1992).
Lin, Tsau-Yen et al., "Inhibition of Cathespin D by Synthetic Olgopeptides" Journal of Biological Chemistry 254(23) :11875-11883 (1979).
Lin, Tsau-Yen et al., "Inhibition of cathepsin D by synthetic oligopeptides" Chemical Abstracts (abstract only) 92(1) :abstract No. 2280 (1980).
Stavropoulos et al., "Synthesis of potent agonists of Substance P by replacement of Met11 with Glu(OBzl) and N-terminal glutamine with Glp of the C-terminal hexapeptide and heptapeptide of Substance P" Int. J. Peptide Protein Res. 45(6):508-513 (1995).
Burnier John P.
Clark Ross G.
Elias Kathleen A.
McDowell Robert S.
Rawson Thomas E.
Genentech Inc.
Lukton David
Schwartz Timothy R.
Trang Cecilia J.
Winter Daryl B.
LandOfFree
Low molecular weight peptidomimetic growth hormone secretagogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Low molecular weight peptidomimetic growth hormone secretagogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low molecular weight peptidomimetic growth hormone secretagogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36377